The Prophylaxis and Treatment with Antiviral Agents of Respiratory Syncytial Virus Infections-Reference-Cited by-同舟云学术

The Prophylaxis and Treatment with Antiviral Agents of Respiratory Syncytial Virus Infections

Published:2012-02 Issue:4 Volume:22 Page:139-150
ISSN:2040-2066
Container-title:Antiviral Chemistry and Chemotherapy
language:en
Short-container-title:Antivir Chem Chemother

Author:

Najarro Pilar¹,Angell Richard²,Powell Kenneth³

Affiliation:

1. Biolty SL, Madrid, Spain

2. University of Sussex, Brighton, UK

3. Q-Chip Ltd, Cardiff, UK

Abstract

In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus (RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.3851/IMP1873

Reference68 articles.

1. Respiratory syncytial virus market

2. Pharmacotherapy of respiratory syncytial virus infection

3. Respiratory Syncytial Virus Infections within Families

4. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries

5. Natural Reinfection of Adults by Respiratory Syncytial Virus

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State of the Art in Respiratory Syncytial Virus Drug Discovery and Development;Journal of Medicinal Chemistry;2018-11-09

2. Antiviral Drugs for Acute Infections;Comprehensive Medicinal Chemistry III;2017

3. Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study;Journal of Medicinal Chemistry;2015-01-27

4. Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein;Virology Journal;2014-11-19